Patent · US Active

Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea

US8217172B2 · kind B2 · utility

0Cited by

10References

12Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Rossitza Gueorguieva Alargova · Watertown, US
Irina Kadiyala · Newton, US
Arnaud Le Tiran · Chatou, FR
Dainius Macikenas · Watertown, US
Yeugang Zhang · Wayland, US

Key dates

Filing date	Dec 5, 2008
Grant date	Jul 10, 2012
Priority date	—
Expiry date	Feb 19, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Solid forms of crystalline1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea, compositions containing solid forms of crystalline1 -ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea and methods of using the same are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.